Back to all studies
Not Yet RecruitingNCT07009158

Ketamine Infusion for PTSD

This study is not yet recruiting. It is testing ketamine Infusion for PTSD.

PTSD, Chronic Pain, ...DrugFrom 18 Years to 64 Years

The public registry lists this study as not yet recruiting. Check the official record and ask the research team when recruitment may open.

Need help deciding?

Ask HopeStage to review this study with me

Loading the security check...
Study ID: NCT07009158. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

Check the official registry

No specific site is confirmed in the available information. Check the official source for locations and remote participation.

In plain English

Key information made simple

This summary needs review. Please check the official study record and contact the research team for details.

What to expect

Your next step

Participation locations and format are not confirmed in the available information. Ask the research team to confirm the location, any in-person visits, time commitment, costs or compensation, and participation criteria.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateEstimated: October 2025
Recruitment status
Not Yet Recruiting
Enrollment listed in the registry
30
Sponsor
Queen's University
Sponsor type
University
Study type
Drug
Intervention type
Psychotherapy / behavioral intervention, Medication / drug
Study phase
Phase 1, Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
Not clearly listed
Age range
From 18 Years to 64 Years
Official registry ID
NCT07009158
Official title
Ketamine Assisted Psychotherapy to Improve Quality of Life in Veterans and Civilians With Comorbid Chronic Pain and Posttraumatic Stress Disorder: an Open-label Randomized Controlled Trial.
Official source
Official registry link

Want help reviewing this study?

Loading the security check...
Study ID: NCT07009158. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Confirm the location and whether remote participation is possible with the research team.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

Based on the public registry summary, this study is trying to understand: The goal of this pilot study is to evaluate the feasibility of conducting a clinical trial assessing if ketamine infusions combined to mindfulness therapy works better than psychotherapy alone to treat chronic pain and PTSD in adults living with both conditions. The objectives. The study team can confirm the exact objective and what it means for you.

Does this study involve a medication?

This appears to be a medication / drug study involving Ketamine Infusion, Mindfulness-based cognitive therapy. Phase 1 studies usually focus mainly on safety, tolerability, dosage, and side effects. They often involve healthy volunteers, but not always. Some Phase 1 studies include people living with the target condition.

Who might this study be for?

This study may concern people with ptsd; age range: From 18 Years to 64 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

What practical constraints should I expect?

The likely practical burden appears high. Things to check include multiple visits or assessments, medical follow-up. Ask the study team about duration, visits, possible compensation, data access, and what happens if you want to stop.

Who is behind this study?

This study is sponsored by Queen's University, which appears to be a university. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not yet recruiting. Check the official record and ask the research team when recruitment may open.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me